Home
NewsNewsTest tube baby treatment will begin at the Castle Street Hospital, expanding IVF access in public healthcare system of Sri Lanka for couples facing infertility and marking a new chapter in the reproductive health services of the nation.
Sri Lanka introduces test tube baby treatment at the Castle Street Hospital for Women in Colombo, marking the first time IVF services will be offered through a government hospital.
The official said this facility would mean that in vitro fertilization, or IVF, would be available under the public healthcare sector. Till date, fertility treatments have been limited to private hospitals only. He added that this will help couples who cannot afford expensive treatments at private hospitals.
Director of the Castle Street Hospital for Women, Dr. Ajith Kumara Danthanarayana said the facility is nearing readiness.
“The new facility is expected to be operational within the next three months. This is an important step in providing advanced reproductive health services through the public healthcare system,”
“Our aim is to ensure that couples who cannot afford expensive private treatment are given a fair opportunity to fulfill their dream of parenthood,” he said.
At present, test tube baby treatment in Sri Lanka is available only at a small number of private hospitals, where a single IVF cycle typically costs between Rs. 2 million and Rs. 3 million.
IVF is a procedure in which an egg is fertilized with sperm outside the body in a lab and then put into the uterus. IVF treatment is being performed to overcome infertility caused by blocked fallopian tubes, low sperm count, an imbalance of hormones, or even unknown causes.
Doctors said that initiating an IVF facility in a government hospital will be a welcome step, as increasing numbers of couples are suffering from infertility problems and facing mental trauma for not being able to access treatment.
Wisconsin lawmakers from both parties are proposing bills to reduce IVF treatment costs. Republicans suggest a $5,000 tax credit for expenses, while Democrats want mandatory insurance coverage. With IVF cycles costing $20,000-$30,000 and 170,000 residents facing infertility, both parties seek affordable solutions through different approaches.
The AI-specialized Infertility Center, which is the largest in Asia, is open in Magok, Seoul and has begun its full-scale medical services from November 17 thereby marking the new era when it comes to fertility in the region.
Alife Health secured CE Mark approval for its AI-powered embryo selection tool, Embryo Predict, under EU MDR, expanding its fertility technology presence across Europe.
Simbryo Technologies introduces the Simbryo FX personalized assay, a diagnostic test that measures endometrial fertility to predict embryo implantation success and improve IVF outcomes with more than 90% specificity.
South Korean couples travel abroad for gender-selective IVF procedures, spending dollars in Thailand and Cyprus due to domestic legal restrictions on choosing a baby's sex.
As more families pursue fertility treatments, IVF CRYO urges greater transparency and safety in better Safe Embryos and Eggs Shipping across the U.S.
China sees a rise in advanced maternal age In Vitro Fertilization, driven by BaseCare Medical’s AI undisturbed culture system that improves embryo quality and clinical pregnancy rates, especially with PGT. Localized AI-assisted solutions position BaseCare as a leader in smart, precision reproduction technology for older IVF patients.
